Roche will buy Roivant’s ulcerative colitis drug named RVT-3101, for $7.1bn aft...
The US Food and Drug Administration (FDA) has approved Pfizer’s PENBRAYA (MenAB...
Hengst is consolidating its expertise in the field of industrial air filtration...
The US Food and Drug Administration (FDA) has approved Celltrion USA’s Zymfentr...
The diagnosed prevalent population of patients with Parkinson’s disease (PD) ac...
On 2 October, Eli Lilly announced that the US Food and Drug Administration (FDA...
At the European Society of Medical Oncology (ESMO) Congress on October 20–24, 2...
At the European Society of Medical Oncology (ESMO) Congress on 20-24 October 20...
BioMarin Pharmaceutical has seen its supplemental New Drug Application (sNDA) f...
Aligos Therapeutics has initiated a securities purchase agreement for private p...
A Roche drug slashed the risk of recurrence or death by 76% versus chemotherapy ...
US biopharma company Meilleur Technologies has entered a research collaboration...
Roche has posted a 7% rise in group sales to SFr14.27bn ($15.91bn) at constant ...
The European Commission (EC) has granted unconditional approval to Pfizer for i...
Tourmaline Bio has completed the merger with Talaris Therapeutics and will begi...
Artificial intelligence (AI) is going to effect almost a fifth of jobs at the hi...
